Dewpoint is translating new insights into biomolecular condensates and cellular function to uncover treatments for the toughest diseases. Dewpoint is harnessing recent insights into biomolecular condensates elucidated by founders Anthony Hyman of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden and Richard Young of the Whitehead Institute with the goal to uncover treatments for the toughest diseases.
Market
Healthcare
Location
Cambridge,
MA,
USA
Coinvestors
6 Dimensions Capital, Alexandria Real Estate Equities, EcoR1 Capital, Leaps by Bayer, Polaris Partners, Samsara BioCapital